What is Annexon's R&D?

Annexon (ANNX) reported R&D of $35.79M in Q1 2026.

How has Annexon's R&D changed year-over-year?

Annexon's R&D decreased by 25.7% year-over-year, from $48.18M to $35.79M.

What is the long-term trend for Annexon's R&D?

Over 4 years (2021 to 2025), Annexon's R&D has grown at a 16.6% compound annual growth rate (CAGR), from $100.07M to $184.7M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Annexon ANNX R&D

R&D at other companies

Regeneron PharmaceuticalsREGN

$1.54B+16.3%

Dianthus TherapeuticsDNTH

$34.53M+27.9%

Vor BiopharmaVOR

$17.6M-34.1%

Cullinan Therapeutics, Inc.CGEM

$42.12M+1.6%

Nektar TherapeuticsNKTR

$35.68M+17.1%

AnaptysBio, Inc.ANAB

$33.99M-17.5%

Other financials

Income statement

See full

Operating income-$46.1M+19.8%

Net income-$44.1M+18.8%

EPS (diluted)-$0.23+37.8%

Balance sheet

See full

Cash & equivalents$175.2M+80.4%

Total debt$25.4M-10.2%

Total equity$204.5M-16.1%

Total assets$262.9M-13.2%

Cash flow

See full

Operating cash flow-$46.8M+6.5%

CapEx--100%

Free cash flow-$46.8M+6.6%

Valuation

See full

Market cap$868.37M+223%

Enterprise value$718.59M+261%

Returns & leverage

See full

Return on equity-87.6%+42.3pp

Debt / equity0.1×0.0×

Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Annexon's R&D?: Annexon (ANNX) reported R&D of $35.79M in Q1 2026.
How has Annexon's R&D changed year-over-year?: Annexon's R&D decreased by 25.7% year-over-year, from $48.18M to $35.79M.
What is the long-term trend for Annexon's R&D?: Over 4 years (2021 to 2025), Annexon's R&D has grown at a 16.6% compound annual growth rate (CAGR), from $100.07M to $184.7M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.